Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 116.79$. Average daily volumn in 3 months 5.54M. Market cap 198.28B



Stock symbol : ABT. Exchange : NYSE. Currency : USD
Lastest price : 113.24$. Total volume : 4.51M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Abbott Laboratories (ABT)
Last Price
113.24$
Change
0.80
Volume
4.51M

Previous Close112.44
Open113.40
Day Range110.82-113.72
Bid112.61 x 900
Ask112.80 x 900
Volume4.51M
Average Volume5.54M
Market Cap198.28B
Beta0.72
52 Week Range104.63-142.60
Trailing P/E26.29
Foward P/E23.25
Dividend (Yield %)1.66%
Ex-Dividend Date2022-04-13



Financial Details


According to Abbott Laboratories's financial reports the company's revenue in 2021 were 43.08B an increase( +26.47%) over the years 2020 revenue that were of 34.61B. In 2021 the company's total earnings were 7.07B while total earnings in 2020 were 4.5B( +75%).


Loading ...



Organization

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Market Cap:
198.28B
Revenue:
43.08B
Total Assets:
75.2B
Total Cash:
9.8B


News about "Abbott Laboratories"

abbott-ceo-apologizes-for-baby-formula-shortage-promises-production-ramp-up-image

Abbott CEO apologizes for baby formula shortage, promises production ramp-up

Source from : MarketWatch - 10 hours ago

Abbott Laboratories Chief Executive Robert Ford apologized Saturday for his company’s role in the nationwide shortage of baby formula and promised ...See details»


what-could-the-baby-formula-shortage-mean-for-abbott-laboratories-image

What Could the Baby Formula Shortage Mean for Abbott Laboratories?

Source from : The Motley Fool on MSN.com - 1 days ago

With the nation's shelves looking a bit too thin on baby formula products, Abbott Laboratories (ABT 0.71%) is in the hot seat. After voluntarily starting a recall of several of it ...See details»


abbott-labs-fda-reach-deal-on-reopening-shuttered-baby-formula-factory-image

Abbott Labs, FDA reach deal on reopening shuttered baby formula factory

Source from : New York Post - 6 days ago

Abbott Laboratories, whose recall of infant formulas made at a Michigan plant has been widely blamed for a nationwide shortage, announced Monday it had reached an agreement with the Food and Drug ...See details»


abbott-labs-fda-reach-deal-to-reopen-baby-formula-manufacturing-plant-image

Abbott Labs, FDA reach deal to reopen baby formula manufacturing plant

Source from : UPI News on MSN.com - 6 days ago

Abbott Laboratories, a key manufacturer of baby formula, said Monday it has reached agreement with regulators to reopen a shuttered production plant amid a nationwide supply shortage.See details»


how-is-the-market-feeling-about-abbott-laboratories-image

How Is The Market Feeling About Abbott Laboratories?

Source from : Benzinga.com - 4 days ago

Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.8% since its last report. The company recently reported that it has 12.79 million shares sold short, which is ...See details»


abbott-laboratories-nyseabt-expected-to-announce-quarterly-sales-of-1033-billion-image

Abbott Laboratories (NYSE:ABT) Expected to Announce Quarterly Sales of $10.33 Billion

Source from : ETF Daily News - 12 days ago

Equities research analysts predict that Abbott Laboratories (NYSE:ABT – Get Rating) will announce sales of $10.33 billion for the current fiscal quarter, Zacks reports. Six analysts have issued ...See details»


abbott-baby-formula-plant-on-track-to-reopen-within-1-2-weeks-fda-commissioner-image

Abbott baby formula plant on track to reopen within 1-2 weeks -FDA commissioner

Source from : YAHOO!News - 3 days ago

Abbott Laboratories and the U.S. Food and Drug Administration are on track to reopen the company's Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert ...See details»


abbott-labs-is-fumbling-the-baby-formula-crisis-image

Abbott Labs is fumbling the baby formula crisis

Source from : Crain's Chicago Business - 6 days ago

Lawyerly denials and officious statements aren't cutting it. CEO Robert Ford has been nearly invisible in this calamity. Time for him to step up and reassure the parents of his most vulnerable ...See details»


abbott-labs-strikes-fda-deal-to-restart-baby-formula-plant-in-michigan-image

Abbott Labs strikes FDA deal to restart baby formula plant in Michigan

Source from : WJBK - 4 days ago

After the FDA confirms Abbott has met the initial requirements in the agreement, it has been reported that the company could get the plant back online within two weeks.See details»


abbott-labs-fda-just-took-a-step-to-getting-more-baby-formula-on-shelves-how-soon-image

Abbott Labs, FDA just took a step to getting more baby formula on shelves. How soon?

Source from : Fort Worth Star-Telegram - 6 days ago

Texas Sen. Ted Cruz urged Biden and the FDA to move swiftly to help end the “crisis” of parents unable to find formula on store shelves.See details»


pelosi-floats-abbott-labs-indictment-over-baby-formula-crisis-image

Pelosi floats Abbott Labs indictment over baby formula crisis

Source from : Crain's Chicago Business - 5 days ago

During a press conference announcing $28 million of proposed emergency funds, Democrats blasted the North Chicago-based manufacturer.See details»


they-messed-up-buttigieg-places-blame-for-baby-formula-shortage-squarely-on-abbott-laboratories-image

They ‘Messed Up’: Buttigieg Places Blame for Baby Formula Shortage Squarely on Abbott Laboratories

Source from : Mediaite on MSN.com - 7 days ago

Transportation Secretary Pete Buttigieg blamed Abbott Laboratories for the baby formula shortage on Sunday, saying the situation was fundamentally caused "because a company was not able to guarantee ...See details»


where-abbott-laboratories-stands-with-analysts-image

Where Abbott Laboratories Stands With Analysts

Source from : Benzinga.com - 5 days ago

According to 4 analyst offering 12-month price targets in the last 3 months, Abbott Laboratories has an average price target of $138.25 with a high of $150.00 and a low of $125.00. Below is a summary ...See details»


abbott-labs-strikes-fda-deal-to-reopen-baby-formula-plant-in-sturgis-amid-shortage-image

Abbott Labs strikes FDA deal to reopen baby formula plant in Sturgis amid shortage

Source from : YAHOO!News - 4 days ago

As infant formula maker Abbott Nutrition enters into an agreement with the FDA to reopen its plant in southwest Michigan, attorney Dionne Webster-Cox is urging parents to take caution.See details»